Free Trial

Ultragenyx Pharmaceutical (RARE) Institutional Ownership

Ultragenyx Pharmaceutical logo
$42.69 -1.79 (-4.03%)
As of 03:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Ultragenyx Pharmaceutical (NASDAQ:RARE)

Current
Institutional Ownership
Percentage
97.67%
Number of
Institutional Buyers
(last 12 months)
177
Total
Institutional Inflows
(last 12 months)
$776.91M
Number of
Institutional Sellers
(last 12 months)
108
Total
Institutional Outflows
(last 12 months)
$665.13M
Get RARE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RARE Institutional Buying and Selling by Quarter

Ultragenyx Pharmaceutical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/20/2025 Mackenzie Financial Corp16,115$678K0.0%+275.6%0.017%
2/19/2025 GF Fund Management CO. LTD.1,939$82K0.0%N/A0.002%
2/19/2025 Public Employees Retirement System of Ohio30,505$1.28M0.0%-6.8%0.033%
2/18/2025 Frazier Life Sciences Management L.P.658,715$27.71M1.2%+3.9%0.713%
2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC202,376$8.51M0.0%+13.9%0.219%
2/17/2025 Woodline Partners LP269,556$11.34M0.1%+0.7%0.292%
2/17/2025 Vestal Point Capital LP1,500,000$63.11M3.7%+100.0%1.624%
2/17/2025 Squarepoint Ops LLC87,989$3.70M0.0%N/A0.095%
2/17/2025 Twinbeech Capital LP33,857$1.42M0.0%+531.7%0.037%
2/17/2025 Two Sigma Advisers LP913,500$38.43M0.1%-7.5%0.989%
2/17/2025 Two Sigma Investments LP614,948$25.87M0.1%-18.6%0.666%
2/17/2025 Tidal Investments LLC13,025$548K0.0%-4.8%0.014%
2/17/2025 Teza Capital Management LLC5,857$246K0.0%+20.4%0.006%
2/17/2025 Stempoint Capital LP101,809$4.28M1.1%N/A0.110%
2/17/2025 Sherbrooke Park Advisers LLC10,387$437K0.1%N/A0.011%
2/17/2025 Sphera Funds Management LTD.228,776$9.63M1.7%+17.1%0.248%
2/17/2025 Rafferty Asset Management LLC101,293$4.26M0.0%+2.9%0.110%
2/17/2025 Point72 Asset Management L.P.1,182,877$49.76M0.1%+81.0%1.281%
2/17/2025 Point72 Hong Kong Ltd27,399$1.15M0.1%+173.4%0.030%
2/17/2025 Quantinno Capital Management LP5,013$211K0.0%N/A0.005%
2/17/2025 MPM Bioimpact LLC391,018$16.45M2.3%+18.6%0.423%
2/17/2025 Parkman Healthcare Partners LLC100,159$4.21M0.6%-8.5%0.108%
2/17/2025 Man Group plc297,394$12.51M0.0%-9.1%0.322%
2/17/2025 Nuveen Asset Management LLC388,661$16.35M0.0%-1.0%0.421%
2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 22,284$937K0.1%-51.8%0.024%
2/17/2025 Millennium Management LLC697,236$29.33M0.0%-1.9%0.755%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.65,734$2.77M0.0%-8.8%0.071%
2/17/2025 Hudson Bay Capital Management LP377,500$15.88M0.1%+93.6%0.409%
2/17/2025 Graham Capital Management L.P.59,129$2.49M0.0%+37.5%0.064%
2/17/2025 Fred Alger Management LLC466,265$19.62M0.1%-13.1%0.505%
2/17/2025 D. E. Shaw & Co. Inc.286,079$12.04M0.0%+9.4%0.310%
2/17/2025 Deutsche Bank AG1,693,108$71.23M0.0%+0.2%1.834%
2/17/2025 DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main346,597$14.58M0.0%+17.6%0.375%
2/17/2025 Driehaus Capital Management LLC829,465$34.90M0.3%+5.8%0.898%
2/17/2025 Deep Track Capital LP653,513$27.49M1.0%N/A0.708%
2/17/2025 Crestline Management LP27,949$1.18M0.0%N/A0.030%
2/17/2025 Cutter Capital Management LP406,803$17.11M7.0%+41.8%0.441%
2/17/2025 BOKF NA7,976$336K0.0%+5.0%0.009%
2/17/2025 Brevan Howard Capital Management LP35,201$1.48M0.0%+116.7%0.038%
2/17/2025 Avidity Partners Management LP352,000$14.81M1.5%-53.2%0.381%
Nvidia > DeepSeek (Ad)

Everyone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long run … that's a good thing.

Click here to see why Nvidia's bad day could end up being a great year.
2/17/2025 Bamco Inc. NY40,000$1.68M0.0%-16.7%0.043%
2/17/2025 Bayesian Capital Management LP8,268$348K0.0%-40.2%0.009%
2/17/2025 Bank of America Corp DE388,502$16.34M0.0%-58.0%0.421%
2/17/2025 BNP Paribas Financial Markets142,628$6M0.0%+394.7%0.154%
2/17/2025 Ameriprise Financial Inc.13,396$564K0.0%+8.4%0.015%
2/17/2025 Algert Global LLC82,793$3.48M0.1%+12.0%0.090%
2/17/2025 Alkeon Capital Management LLC1,686,716$70.96M0.1%-44.0%1.827%
2/17/2025 Alyeska Investment Group L.P.1,439,740$60.57M0.2%+23.1%1.559%
2/17/2025 AXA S.A.456,588$19.21M0.1%+7.3%0.494%
2/17/2025 Acuta Capital Partners LLC21,000$883K0.9%-16.3%0.023%
2/14/2025 PDT Partners LLC48,859$2.06M0.2%-26.2%0.053%
2/14/2025 AQR Capital Management LLC280,547$11.80M0.0%-73.1%0.304%
2/14/2025 Emerald Mutual Fund Advisers Trust324,437$13.65M0.8%-24.4%0.351%
2/14/2025 First Light Asset Management LLC763,607$32.13M3.1%+1.1%0.827%
2/14/2025 Northern Trust Corp528,965$22.25M0.0%+11.8%0.573%
2/14/2025 The Manufacturers Life Insurance Company 216,587$9.11M0.0%-9.0%0.235%
2/14/2025 Quarry LP2,000$84K0.0%N/A0.002%
2/14/2025 Aquatic Capital Management LLC102,571$4.32M0.1%+327.4%0.111%
2/14/2025 Birchview Capital LP16,000$673K0.5%N/A0.017%
2/14/2025 Gilder Gagnon Howe & Co. LLC16,928$712K0.0%-13.6%0.018%
2/14/2025 Nebula Research & Development LLC8,876$373K0.0%+110.3%0.010%
2/14/2025 Voya Investment Management LLC72,321$3.04M0.0%-55.4%0.078%
2/14/2025 Blue Owl Capital Holdings LP118,238$4.97M1.2%-27.6%0.128%
2/14/2025 Adage Capital Partners GP L.L.C.1,183,081$49.77M0.1%-22.5%1.281%
2/14/2025 Syon Capital LLC7,362$310K0.0%N/A0.008%
2/14/2025 Price T Rowe Associates Inc. MD2,512,423$105.70M0.0%-18.1%2.721%
2/14/2025 Dark Forest Capital Management LP10,916$459K0.1%N/A0.012%
2/14/2025 Silverarc Capital Management LLC124,388$5.23M1.1%N/A0.135%
2/14/2025 Hsbc Holdings PLC47,516$1.98M0.0%+195.1%0.051%
2/14/2025 Rock Springs Capital Management LP1,739,813$73.19M2.8%-12.1%1.884%
2/14/2025 Stifel Financial Corp23,796$1.00M0.0%+13.5%0.026%
2/14/2025 Tower Research Capital LLC TRC 16,827$708K0.0%+1,872.7%0.018%
2/14/2025 First Trust Advisors LP544,202$22.89M0.0%+3,097.1%0.589%
2/13/2025 CANADA LIFE ASSURANCE Co23,153$972K0.0%-2.7%0.025%
2/13/2025 Marshall Wace LLP1,051,573$44.24M0.1%+27.9%1.139%
2/13/2025 NFJ Investment Group LLC37,667$1.59M0.1%-1.2%0.041%
2/13/2025 Jump Financial LLC112,816$4.75M0.1%+351.4%0.122%
2/13/2025 Guggenheim Capital LLC45,222$1.90M0.0%+1.5%0.049%
2/13/2025 XTX Topco Ltd11,248$473K0.0%-23.1%0.012%
2/13/2025 Barclays PLC206,108$8.67M0.0%+159.1%0.223%
2/13/2025 Granite Investment Partners LLC160,415$6.75M0.3%-8.3%0.174%
2/13/2025 Treasurer of the State of North Carolina39,051$1.64M0.0%-0.8%0.042%
2/13/2025 Capital Fund Management S.A.34,225$1.44M0.0%-6.3%0.037%
2/13/2025 F M Investments LLC42,004$1.77M0.1%N/A0.045%
2/13/2025 Raymond James Financial Inc.21,774$916K0.0%N/A0.024%
2/13/2025 Renaissance Technologies LLC254,700$10.72M0.0%+39.9%0.276%
2/13/2025 Legal & General Group Plc98,732$4.15M0.0%-3.1%0.107%
2/13/2025 Invesco Ltd.1,699,756$71.51M0.0%+1.5%1.841%
2/13/2025 ADAR1 Capital Management LLC8,000$337K0.1%N/A0.009%
2/13/2025 Aster Capital Management DIFC Ltd825$35K0.0%N/A0.001%
This Crypto Is Set to Explode in February (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

2/13/2025 Federated Hermes Inc.2,049,800$86.24M0.2%-2.9%2.220%
2/13/2025 Russell Investments Group Ltd.69,187$2.91M0.0%-21.9%0.075%
2/13/2025 Envestnet Asset Management Inc.34,288$1.44M0.0%-7.6%0.037%
2/13/2025 Wells Fargo & Company MN30,371$1.28M0.0%-8.7%0.033%
2/12/2025 Pitcairn Co.8,342$351K0.0%-21.2%0.009%
2/12/2025 ExodusPoint Capital Management LP87,017$3.66M0.0%N/A0.094%
2/12/2025 Motley Fool Asset Management LLC48,448$2.04M0.1%-65.8%0.052%
2/12/2025 Cinctive Capital Management LP62,960$2.65M0.1%+295.9%0.068%
2/12/2025 Bryce Point Capital LLC10,719$451K0.1%N/A0.012%
2/12/2025 Massachusetts Financial Services Co. MA500,717$21.07M0.0%-7.7%0.542%
(Data available from 1/1/2016 forward)

RARE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RARE shares?

During the previous two years, 274 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical. The most heavily invested institutionals were Vanguard Group Inc. ($422.17M), Sands Capital Management LLC ($196.92M), State Street Corp ($147.99M), RTW Investments LP ($109.32M), Price T Rowe Associates Inc. MD ($105.70M), Wellington Management Group LLP ($103.39M), and Clearbridge Investments LLC ($97.70M).Learn more on RARE's institutional investors.

What percentage of Ultragenyx Pharmaceutical stock is owned by institutional investors?

97.67% of Ultragenyx Pharmaceutical stock is owned by institutional investors. Learn more on RARE's institutional investor holdings.

Which institutional investors have been buying Ultragenyx Pharmaceutical stock?

Of the 237 institutional investors that purchased Ultragenyx Pharmaceutical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($1.79M), Vanguard Group Inc. ($1.77M), Norges Bank ($1.73M), Sands Capital Management LLC ($1.54M), Millennium Management LLC ($942.53K), Federated Hermes Inc. ($838.25K), and Alkeon Capital Management LLC ($769.88K).

How much institutional buying is happening at Ultragenyx Pharmaceutical?

Institutional investors have bought a total of 27,575,051 shares in the last 24 months. This purchase volume represents approximately $1.23B in transactions.

Which Ultragenyx Pharmaceutical major shareholders have been selling company stock?

Of the 145 institutional investors that sold Ultragenyx Pharmaceutical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($2.98M), Alkeon Capital Management LLC ($1.33M), RTW Investments LP ($1.29M), Suvretta Capital Management LLC ($1.19M), Avoro Capital Advisors LLC ($1.15M), Vestal Point Capital LP ($1.05M), and AQR Capital Management LLC ($917.92K).

How much institutional selling is happening at Ultragenyx Pharmaceutical?

Institutional investors have sold a total of 19,506,796 shares in the last 24 months. This volume of shares sold represents approximately $900.58M in transactions.



This page (NASDAQ:RARE) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners